Steakholder Foods's EBIT is $-7.7M, below the Healthcare sector average of $23B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2025
Trailing 12 months ending Jun 30, 2025
The latest EBIT for STKH is $-7.7M as of June 2025. That compares with $-4.4M in the prior-year period — down 76.8% year over year. That is below the Healthcare sector average of $23B. Investors often review this figure alongside Steakholder Foods's historical trend and sector peers before judging valuation or financial health.
Over the past year, STKH's EBIT moved from $-4.4M to $-7.7M — a 76.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Steakholder Foods's operating scale or balance-sheet position.
Against Healthcare companies, STKH currently prints $-7.7M for EBIT, while the sector average sits near $23B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Steakholder Foods's growth, margins, and balance sheet.
A EBIT figure of $-7.7M for STKH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $23B. Explore the charts below for those layers of context.
After noting STKH's EBIT ($-7.7M), review year-over-year change from $-4.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.